Valproate inhibits MAP kinase signalling and cell cycle progression in S. cerevisiae.

Desfossés-Baron, Kristelle and Hammond-Martel, Ian and Simoneau, Antoine and Sellam, Adnane and Roberts, Stephen Kenneth and Wurtele, Hugo (2016) Valproate inhibits MAP kinase signalling and cell cycle progression in S. cerevisiae. Scientific Reports, 6. pp. 1-14. ISSN 2045-2322

Full text not available from this repository.


The mechanism of action of valproate (VPA), a widely prescribed short chain fatty acid with anticonvulsant and anticancer properties, remains poorly understood. Here, the yeast Saccharomyces cerevisiae was used as model to investigate the biological consequences of VPA exposure. We found that low pH strongly potentiates VPA-induced growth inhibition. Transcriptional profiling revealed that under these conditions, VPA modulates the expression of genes involved in diverse cellular processes including protein folding, cell wall organisation, sexual reproduction, and cell cycle progression. We further investigated the impact of VPA on selected processes and found that this drug: i) activates markers of the unfolded protein stress response such as Hac1 mRNA splicing; ii) modulates the cell wall integrity pathway by inhibiting the activation of the Slt2 MAP kinase, and synergizes with cell wall stressors such as micafungin and calcofluor white in preventing yeast growth; iii) prevents activation of the Kss1 and Fus3 MAP kinases of the mating pheromone pathway, which in turn abolishes cellular responses to alpha factor; and iv) blocks cell cycle progression and DNA replication. Overall, our data identify heretofore unknown biological responses to VPA in budding yeast, and highlight the broad spectrum of cellular pathways influenced by this chemical in eukaryotes.

Item Type:
Journal Article
Journal or Publication Title:
Scientific Reports
Uncontrolled Keywords:
ID Code:
Deposited By:
Deposited On:
16 Nov 2016 13:20
Last Modified:
15 Sep 2023 00:30